13 February 2017
IQE plc
("IQE" or the "Company")
Holding(s) in Company
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | IQE PLC | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | X | |||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
| An event changing the breakdown of voting rights | ||||
| Other (please specify): | ||||
| 3. Full name of person(s) subject to the notification obligation: iii | T. Rowe Price Associates, Inc. | |||
| 4. Full name of shareholder(s) (if different from 3.):iv | JP Morgan Chase Bank of New York Mellon Bank Northern Trust Company | |||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v | 09 February 2017 | |||
| 6. Date on which issuer notified: | 13 February 2017 | |||
| 7. Threshold(s) that is/are crossed or reached: vi, vii | 12% | |||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to shares viii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| GB0009619924 | 81,300,209 | 81,300,209 | 80,932,225 | 80,932,225 | 11.97% | |||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| | Nominal | Delta | ||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 80,932,225 | 11.97% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
| T. Rowe Price Associates, Inc. (TRPA) serves as investment adviser, with dispositive and voting authority, to various institutional clients that own shares of IQE Plc, including the T. Rowe Price International Discovery Fund, which owns 64,266,013 shares. Such shares are registered in the following name(s): JP Morgan Chase - 75,143,340 Bank of New York Mellon - 4,957,847 Northern Trust Company - 831,038 | ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: | ||
| 12. Date on which proxy holder will cease to hold voting rights: | ||
| 13. Additional information: | | |
| 14. Contact name: | Gary Greb, Vice President T. Rowe Price Associates, Inc. | |
| 15. Contact telephone number: | 001 410 345 2527 | |